Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial.

Jose Ignacio BernardinoAmanda MocroftCedrick WalletStéphane de WitChristine KatlamaPeter ReissPatrick W MallonLaura RichertJean-Michel MolinaHernando KnobelPhilippe MorlatAbdel BabikerAnton PozniacFrancois RaffiJose R Arribasnull null

Published in: PloS one (2019)

After week 96 a N(t)RTI sparing regimen of DRV/r + RAL produced a numerically greater percentage increase in body composition variables with only change in trunk fat mass and BMI being significant.

Keyphrases

body composition
resistance training
bone mineral density
hiv infected patients
antiretroviral therapy
body mass index
study protocol
randomized controlled trial
clinical trial
robot assisted
open label
combination therapy
weight gain
physical activity
placebo controlled